A Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection

2022/11/01 by Mark Haas, James Mirocha, Edmund Huang +7 · 4 citations
Medicine · #Renal Transplantation Outcomes and Treatments #Renal Diseases and Glomerulopathies #Organ Transplantation Techniques and Outcomes

paper · doi:10.1016/j.kint.2022.09.030

Citations

• A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology

Cited by

• A randomized controlled trial of intravenous immunoglobulin vs standard of care for the treatment of chronic active antibody-mediated rejection in kidney transplant recipients
• Antibody-mediated rejection—treatment standard
• Intravenous immunoglobulin for chronic active antibody-mediated rejection: a signal of hope in an evolving field
• One tool, multiple gains: anti-CD38 therapy in antibody-mediated rejection